VIM and juvenile idiopathic arthritis: Four of the 10 (40.0%) JIA patients’ positive for anti-citrullinated vimentin aa 1–16 antibodies and 6/7 positive for anti-citrullinated vimentin aa 59–74 antibodies (85.7%) were also positive for IgM RF.